1. Bunpa S, Sermwittayawong N, Vuddhakul V. Extracellular enzymes produced by
Vibrio alginolyticus isolated from environments and diseased aquatic animals. Procedia Chem 2016;18:12–17.
2. Xu Y, Wang C, Zhang G, Tian J, Liu Y, Shen X,
et al. ISCR2 is associated with the dissemination of multiple resistance genes among
Vibrio spp. and
Pseudoalteromonas spp. isolated from farmed fish. Arch Microbiol 2017;199:891–896.
3. Khouadja S, Lamari F, Bakhrouf A. Characterization of
Vibrio parahaemolyticus isolated from farmed sea bass (
Dicentrarchus labrax) during disease outbreaks. Int Aquat Res 2013;5:13.
4. Abdullah A, Ramli R, Ridzuan MS, Murni M, Hashim S, Sudirwan F,
et al. The presence of Vibrionaceae,
Betanodavirus and
Iridovirus in marine cage-cultured fish: role of fish size, water physicochemical parameters and relationships among the pathogens. Aquac Rep 2017;7:57–65.
5. Dong HT, Taengphu S, Sangsuriya P, Charoensapsri W, Phiwsaiya K, Sornwatana T,
et al. Recovery of
Vibrio harveyi from scale drop and muscle necrosis disease in farmed barramundi,
Lates calcarifer in Vietnam. Aquaculture 2017;473:89–96.
6. Mohamad N, Mohd Roseli FA, Azmai MN, Saad MZ, Md Yasin IS, Zulkiply NA,
et al. Natural concurrent infection of
Vibrio harveyi and
V. alginolyticus in cultured hybrid groupers in Malaysia. J Aquat Anim Health 2019;31:88–96.
7. Haldar S, Maharajan A, Chatterjee S, Hunter SA, Chowdhury N, Hinenoya A,
et al. Identification of
Vibrio harveyi as a causative bacterium for a tail rot disease of sea bream
Sparus aurata from research hatchery in Malta. Microbiol Res 2010;165:639–648.
8. Cabello FC, Godfrey HP, Tomova A, Ivanova L, Dolz H, Millanao A,
et al. Antimicrobial use in aquaculture re-examined: its relevance to antimicrobial resistance and to animal and human health. Environ Microbiol 2013;15:1917–1942.
9. Thirugnanasambandam R, Inbakandan D, Kumar C, Subashni B, Vasantharaja R, Stanley Abraham L,
et al. Genomic insights of
Vibrio harveyi RT-6 strain, from infected "Whiteleg shrimp" (
Litopenaeus vannamei) using Illumina platform. Mol Phylogenet Evol 2019;130:35–44.
10. Austin B, Zhang XH. Vibrio harveyi: a significant pathogen of marine vertebrates and invertebrates. Lett Appl Microbiol 2006;43:119–124.
12. Leal Y, Velazquez J, Hernandez L, Swain JK, Rodriguez AR, Martinez R,
et al. Promiscuous T cell epitopes boosts specific IgM immune response against a P0 peptide antigen from sea lice in different teleost species. Fish Shellfish Immunol 2019;92:322–330.
13. Ashfaq H, Soliman H, Fajmann S, Sexl V, El-Matbouli M, Saleh M. Kinetics of CD4-1+ lymphocytes in brown trout after exposure to viral haemorrhagic septicaemia virus. J Fish Dis 2021;44:1553–1562.
14. Nakanishi T, Fischer U, Dijkstra JM, Hasegawa S, Somamoto T, Okamoto N,
et al. Cytotoxic T cell function in fish. Dev Comp Immunol 2002;26:131–139.
15. Adams A. Progress, challenges and opportunities in fish vaccine development. Fish Shellfish Immunol 2019;90:210–214.
16. Munoz-Medina JE, Sanchez-Vallejo CJ, Mendez-Tenorio A, Monroy-Munoz IE, Angeles-Martinez J, Santos Coy-Arechavaleta A,
et al.
In silico identification of highly conserved epitopes of influenza A H1N1, H2N2, H3N2, and H5N1 with diagnostic and vaccination potential. Biomed Res Int 2015;2015:813047.
17. Ali MT, Morshed MM, Hassan F. A computational approach for designing a universal epitope-based peptide vaccine against Nipah virus. Interdiscip Sci 2015;7:177–185.
18. Anwar S, Mourosi JT, Khan MF, Hosen MJ. Prediction of epitope-based peptide vaccine against the Chikungunya virus by immuno-informatics approach. Curr Pharm Biotechnol 2020;21:325–340.
20. Shi J, Zhang J, Li S, Sun J, Teng Y, Wu M,
et al. Epitope-based vaccine target screening against highly pathogenic MERS-CoV: an in silico approach applied to emerging infectious diseases. PLoS One 2015;10:e0144475.
25. Bolnick DI, Snowberg LK, Caporaso JG, Lauber C, Knight R, Stutz WE. Major histocompatibility complex class IIb polymorphism influences gut microbiota composition and diversity. Mol Ecol 2014;23:4831–4845.
26. Marana MH, Jorgensen LV, Skov J, Chettri JK, Holm Mattsson A, Dalsgaard I,
et al. Subunit vaccine candidates against
Aeromonas salmonicida in rainbow trout
Oncorhynchus mykiss. PLoS One 2017;12:e0171944.
27. Mahendran R, Jeyabaskar S, Sitharaman G, Michael RD, Paul AV. Computer-aided vaccine designing approach against fish pathogens
Edwardsiella tarda and
Flavobacterium columnare using bioinformatics softwares. Drug Des Devel Ther 2016;10:1703–1714.
28. Pereira UP, Soares SC, Blom J, Leal CA, Ramos RT, Guimaraes LC,
et al.
In silico prediction of conserved vaccine targets in
Streptococcus agalactiae strains isolated from fish, cattle, and human samples. Genet Mol Res 2013;12:2902–2912.
29. Pumchan A, Krobthong S, Roytrakul S, Sawatdichaikul O, Kondo H, Hirono I,
et al. Novel chimeric multiepitope vaccine for streptococcosis disease in Nile Tilapia (
Oreochromis niloticus Linn.). Sci Rep 2020;10:603.
30. Madonia A, Melchiorri C, Bonamano S, Marcelli M, Bulfon C, Castiglione F,
et al. Computational modeling of immune system of the fish for a more effective vaccination in aquaculture. Bioinformatics 2017;33:3065–3071.
31. Joshi A, Pathak DC, Mannan MA, Kaushik V.
In-silico designing of epitope-based vaccine against the seven banded grouper nervous necrosis virus affecting fish species. Netw Model Anal Health Inform Bioinform 2021;10:37.
32. Throngnumchai B, Jitrakorn S, Sangsuriya P, Unajak S, Khunrae P, Dong HT,
et al. Refolded recombinant major capsid protein (MCP) from Infectious Spleen and Kidney Necrosis Virus (ISKNV) effectively stimulates serum specific antibody and immune related genes response in Nile tilapia (
Oreochromis niloticus). Protein Expr Purif 2021;184:105876.
33. Dong C, Xiong X, Luo Y, Weng S, Wang Q, He J. Efficacy of a formalin-killed cell vaccine against infectious spleen and kidney necrosis virus (ISKNV) and immunoproteomic analysis of its major immunogenic proteins. Vet Microbiol 2013;162:419–428.
34. Yuan Y, Feng Z, Wang J.
Vibrio vulnificus hemolysin: biological activity, regulation of vvhA expression, and role in pathogenesis. Front Immunol 2020;11:599439.
36. Magnan CN, Zeller M, Kayala MA, Vigil A, Randall A, Felgner PL,
et al. High-throughput prediction of protein antigenicity using protein microarray data. Bioinformatics 2010;26:2936–2943.
39. Calis JJ, Maybeno M, Greenbaum JA, Weiskopf D, De Silva AD, Sette A,
et al. Properties of MHC class I presented peptides that enhance immunogenicity. PLoS Comput Biol 2013;9:e1003266.
40. Gupta S, Kapoor P, Chaudhary K, Gautam A, Kumar R; Open Source Drug Discovery Cnsortium,
et al.
In silico approach for predicting toxicity of peptides and proteins. PLoS One 2013;8:e73957.
42. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C,
et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420–422.
43. Jensen KK, Andreatta M, Marcatili P, Buus S, Greenbaum JA, Yan Z,
et al. Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology 2018;154:394–406.
44. Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, Bui HH,
et al. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol 2006;24:817–819.
46. Nagpal G, Usmani SS, Dhanda SK, Kaur H, Singh S, Sharma M,
et al. Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential. Sci Rep 2017;7:42851.
47. Nain Z, Abdulla F, Rahman MM, Karim MM, Khan MS, Sayed SB,
et al. Proteome-wide screening for designing a multi-epitope vaccine against emerging pathogen
Elizabethkingia anophelis using immunoinformatic approaches. J Biomol Struct Dyn 2020;38:4850–4867.
50. Chen X, Zaro JL, Shen WC. Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev 2013;65:1357–1369.
52. Dorosti H, Eslami M, Negahdaripour M, Ghoshoon MB, Gholami A, Heidari R,
et al. Vaccinomics approach for developing multi-epitope peptide pneumococcal vaccine. J Biomol Struct Dyn 2019;37:3524–3535.
53. Nain Z, Karim MM, Sen MK, Adhikari UK. Structural basis and designing of peptide vaccine using PE-PGRS family protein of
Mycobacterium ulcerans: an integrated vaccinomics approach. Mol Immunol 2020;120:146–163.
56. Abdellrazeq GS, Fry LM, Elnaggar MM, Bannantine JP, Schneider DA, Chamberlin WM,
et al. Simultaneous cognate epitope recognition by bovine CD4 and CD8 T cells is essential for primary expansion of antigen-specific cytotoxic T-cells following ex vivo stimulation with a candidate
Mycobacterium avium subsp. paratuberculosis peptide vaccine. Vaccine 2020;38:2016–2025.
57. Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD,
et al. Protein identification and analysis tools in the ExPASy server. Methods Mol Biol 1999;112:531–552.
58. Geourjon C, Deleage G. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci 1995;11:681–684.
61. Nugent T, Cozzetto D, Jones DT. Evaluation of predictions in the CASP10 model refinement category. Proteins 2014;82 Suppl 2:98–111.
62. DeLano WL. PyMOL: an open-source molecular graphics tool. CCP4 Newsl Protein Crystallogr 2002;40:82–92.
63. Lovell SC, Davis IW, Arendall WB, de Bakker PI, Word JM, Prisant MG,
et al. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 2003;50:437–450.
65. Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C,
et al. The ClusPro web server for protein-protein docking. Nat Protoc 2017;12:255–278.
66. Pokhrel S, Bouback TA, Samad A, Nur SM, Alam R, Abdullah-Al-Mamun M,
et al. Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2. Int J Biol Macromol 2021;191:1114–1125.
67. Bouback TA, Pokhrel S, Albeshri A, Aljohani AM, Samad A, Alam R,
et al. Pharmacophore-based virtual screening, quantum mechanics calculations, and molecular dynamics simulation approaches identified potential natural antiviral drug candidates against MERS-CoV S1-NTD. Molecules 2021;26:4961.
70. Grote A, Hiller K, Scheer M, Munch R, Nortemann B, Hempel DC,
et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res 2005;33:W526–W531.
71. Goldberg MF, Roeske EK, Ward LN, Pengo T, Dileepan T, Kotov DI,
et al.
Salmonella persist in activated macrophages in T cell-sparse granulomas but are contained by surrounding CXCR3 ligand-positioned Th1 cells. Immunity 2018;49:1090–1102.
72. Liu X, Sun W, Zhang Y, Zhou Y, Xu J, Gao X,
et al. Impact of
Aeromonas hydrophilaand infectious spleen and kidney necrosis virus infections on susceptibility and host immune response in Chinese perch (
Siniperca chuatsi). Fish Shellfish Immunol 2020;105:117–125.
74. Bol KF, Aarntzen EH, Pots JM, Olde Nordkamp MA, van de Rakt MW, Scharenborg NM,
et al. Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity. Cancer Immunol Immunother 2016;65:327–339.
75. Shamriz S, Ofoghi H, Moazami N. Effect of linker length and residues on the structure and stability of a fusion protein with malaria vaccine application. Comput Biol Med 2016;76:24–29.
76. Bonam SR, Partidos CD, Halmuthur SK, Muller S. An overview of novel adjuvants designed for improving vaccine efficacy. Trends Pharmacol Sci 2017;38:771–793.
77. Khatoon N, Pandey RK, Prajapati VK. Exploring
Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach. Sci Rep 2017;7:8285.